-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Pieris Pharmaceuticals, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q4 2017.
- Pieris Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2017 was $1.08M, a 126% increase year-over-year.
- Pieris Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2017 was $3.05M, a 59.9% increase year-over-year.
- Pieris Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.35M, a 23.9% decline from 2022.
- Pieris Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.4M, a 15.6% decline from 2021.
- Pieris Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.22M, a 2.46% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)